Additionally, other studies have shown that stroke is also associated with NLRP2 and NLRC4 [17, 23] In view of the accelerated progress in elucidating the mechanisms of inflammasomes, their use as therapeutic targets in stroke represents a promising future clinical application. This evidence concerns the gene NLRC4 and Stroke.